| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |